Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test

Inclusion Criteria: * Subject is male between 18 and 35 years of age at the time of screening. * Subject understands the study procedures and agrees to participate in the study by giving written informed consent. * Subject is a non-smoker. * Subject is judged to be in good health based on medical history and brief physical examination. * Subject has normal or corrected to normal visual and auditory acuity. * Subject agrees to refrain from caffeine 24 hours prior to and then throughout each Study Day. * Subject agrees to refrain from using alcohol for 48 hours prior to and then throughout each Study Day. Exclusion Criteria: * Subject has a diagnosis of a significant neurological condition including Alzheimer's disease, Parkinson's disease, vascular dementia, Lewy body dementia or frontal temporal dementia, human immunodeficiency virus, multiple sclerosis, or severe traumatic brain injury. * Subject has a history of primary psychotic disorder (e.g. schizophrenia, schizoaffective disorder, delusional disorder) or bipolar disorder. * Subject has a history of seizures, epilepsy, stroke, peripheral neuropathy, head trauma with persistent post-concussive symptoms, ADHD, dyslexia or other clinically significant neurological disease or cognitive impairment. * Subject has a lifetime or current history of alcohol or substance abuse/dependence. * Subject has a history of multiple or severe allergies, or has had an anaphylactic reaction or intolerability to prescription or non-prescrip…